Clinical Evidence of Acetyl‐L‐Carnitine Efficacy in the Treatment of Acute Ischemic Stroke: A Pilot Clinical Trial

Abstract

Although preliminary, these results suggested that ALC administration during the acute phase of ischemic stroke might be helpful in improving functional and neurological outcomes that are probably linked to its anti-inflammatory and antioxidant properties. <i>Trial Registration</i>. This trial is registered with IRCT20150629022965N17 at Iranian Registry of Clinical Trials (registration date: 25/07/2018).